finds that people with type 2 diabetes who take two common anti-diabetes medications had a reduced risk of Alzheimer’s and associated dementias. Specifically, GLP-1RA was linked to a 33% lower ...

"Historically, anti-obesity drugs have been plagued ... Originally developed for diabetes management, these drugs were later found to have profound weight-loss effects. Among them, semaglutide ...

Recent study shows oral semaglutide reduces cardiovascular risk in type 2 diabetes patients, enhancing diabetes and heart ...